SeekingAlpha · Oct 14, 2026
LZ
OTC · LZAGY
Lonza Group AG
Healthcare · Medical - Diagnostics & Research
$81.90
Up+$0.46 (+0.56%)
Updated Nov 5, 2026, 11:43 PM
SID Score
5.5/10
Composite research score
Smart Money
46/100
Neutral
- Market cap
- 46.5B
- P/E ratio
- 49.81
- Dividend yield
- 0.58%
- 52-week range
- — – —
- Volume
- 26.68K
- Avg. volume
- 81.96K
Price performance · LZAGY
LZAGY price history
1M range · 0 trading sessions · Daily adjusted prices
LZAGY does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest LZAGY news
The latest Smart Investors Daily articles mentioning LZAGY.
Stock researchCompany · Overview
Company
Market Activity
Research & News
LZAGY research
Overview
Company profile and research snapshot.
Company profile
LONZA GROUP AG UNSP/ADR
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- —
- Implied upside
- —
- Analysts
- 13
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 24, 2026 | HSBC GLOBAL INVESTMENT RESEARCH | Buy | — |
| Jul 30, 2026 | BAADER EUROPE / ALPHAVALUE | Buy | — |
| Jul 30, 2026 | BERENBERG | Buy | — |
| Jul 29, 2026 | BNP PARIBAS | Outperform | — |
| Jul 27, 2026 | ODDO BHF | Buy | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Oct 14, 2026
Lonza Group AG (LZAGY) Analyst/Investor Day - Slideshow
2026-10-14. The following slide deck was published by Lonza Group AG in conjunction with this event.
Yahoo · Oct 14, 2026
Lonza raises mid-term margin goal, says Q3 in line with expectations
Investing.com -- Swiss drugmaker services group Lonza raised its mid-term profitability goal on Wednesday, targeting a core EBITDA margin in the high thirties, and said third-quarter performance was in line with expectations.
SeekingAlpha · Oct 7, 2026
Lonza: The Market Is Pricing The Phasing, Not The Return On Capital
Lonza is transitioning into a pure-play CDMO, with capital efficiency improving and ROIC reaching 13.2%. I rate LZAGY stock a buy. Read my full analysis now.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
